Overview
The purpose of this study is to determine the disease progression in CHB/NAFLD compared with CHB and NAFLD including liver cirrhosis, cirrhotic complications and hepatocellular carcinoma (HCC).
Eligibility
Inclusion Criteria:
- Liver biopsy proved CHB and/or NAFLD at baseline;
- Chinese
- Follow-up duration>12 months
Exclusion Criteria:
- Other liver diseases;
- Secondary causes of hepatic steatosis;
- Alcohol abuse;
- Liver cirrhosis, cirrhosis related complications or HCC at baseline;
- Malignancy;
- History of liver transplantation